Dapagliflozin Tablet, Film Coated
Product Images NDC 50090-7972

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dapagliflozin (NDC 50090-7972). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Scatter Plot And Fitted Line Of Change From Baseline In 24-hour Urinary Glucose Amount Versus Dapagliflozin Dose In Healthy Subjects And Subjects With Type 2 Diabetes Mellitus (t2dm) (semi-log Plot) (Dapagliflozin Fig1)

Figure 1: Scatter Plot And Fitted Line Of Change From Baseline In 24-hour Urinary Glucose Amount Versus Dapagliflozin Dose In Healthy Subjects And Subjects With Type 2 Diabetes Mellitus (t2dm) (semi-log Plot) (Dapagliflozin Fig1)
FDA Label Image

Figure 2: Adjusted Mean Change From Baseline Over Time In Hba1c (%) In A 24-week Active-controlled Study Of Dapagliflozin Initial Combination Therapy With Metformin Xr (Dapagliflozin Fig2)

Figure 2: Adjusted Mean Change From Baseline Over Time In Hba1c (%) In A 24-week Active-controlled Study Of Dapagliflozin Initial Combination Therapy With Metformin Xr (Dapagliflozin Fig2)
This text provides information on the adjusted mean change from baseline in HbA1c levels for a study comparing Dapagliflozin 10mg + Metformin, Dapagliflozin 10mg alone, and Metformin alone. The data includes graphs showing values for adjusted mean change over different study weeks and criteria for the subjects included in the analysis. The left side graph is based on a longitudinal repeated measures model, while the right side graph for Week 24 discusses adjusted mean change values based on an ANCOVA model. The analysis is conducted on randomized subjects who completed the study without rescue interventions.*
FDA Label Image

Figure 3 (Dapagliflozin Fig3)

Figure 3 (Dapagliflozin Fig3)
FDA Label Image

Figure (Dapagliflozin Fig4)

Figure (Dapagliflozin Fig4)
FDA Label Image

Figure (Dapagliflozin Fig5)

Figure (Dapagliflozin Fig5)
FDA Label Image

Chemical Structure (Dapagliflozin Str)

Chemical Structure (Dapagliflozin Str)
FDA Label Image

Label Image (Lbl500907972)

Label Image (Lbl500907972)
This is a product description for Dapagliflozin tablets with the product number 7213-0. Each bottle contains 30 tablets. The product should be stored at 8-10 degrees Celsius.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.